首页> 外文期刊>Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract >Distal Pancreatectomy Combined with Multivisceral Resection Is Associated with Postoperative Complication Rates and Survival Comparable to Those After Standard Procedures
【24h】

Distal Pancreatectomy Combined with Multivisceral Resection Is Associated with Postoperative Complication Rates and Survival Comparable to Those After Standard Procedures

机译:远端胰乳酶切除术与多抗体切除相结合,与标准程序后的术后并发症率和存活率相关联

获取原文
获取原文并翻译 | 示例
           

摘要

Background For pancreatic tumors located in the body or tail of the pancreas, distal pancreatectomy (DP) remains the surgical procedure of choice to achieve radical tumor removal. Purpose of this study was to evaluate outcome and overall survival of patients who underwent DP combined with multivisceral resection (MVR). Methods Retrospective single-center case-matched analysis. Between January 1994 and June 2014, 494 consecutive patients were entered into a prospective database, and 126 patients undergoing DP + MVR (cases) were matched with 126 patients undergoing DP (controls) for gender, age, and underlying final diagnosis. Results There were no significant differences in patient demographics. Rates of postoperative pancreatic fistula (POPF) (36 (28.6%) vs. 29 (23.0%); p ?=?0.388) and postpancreatectomy hemorrhage (PPH) (7 (5.5%) vs. 5 (3.9%); p ?=?0.769) did not reveal any significant differences. Although operative time (237.8?±?57.9 vs. 203.5?±?34.5; p ?
机译:用于位于胰腺的胰腺肿瘤的背景,远端胰腺切除术(DP)仍然是实现自由基肿瘤去除的外科手术。本研究的目的是评估接受DP联合多民会切除(MVR)的患者的结果和整体存活。方法回顾性单中心匹配分析。 1994年1月至2014年6月至2014年6月期间,将494名连续患者进入前瞻性数据库,并将126名接受DP + MVR(病例)的患者与接受性别,年龄和潜在的最终诊断进行DP(对照)的126名患者。结果患者人口统计学没有显着差异。术后胰瘘(POPF)的速率(36(28.6%)与29(23.0%); p?= 0.388)和产后切除术出血(PPH)(7(5.5%)与5(3.9%); p? =?0.769)没有揭示任何显着差异。虽然操作时间(237.8?±±57.9与203.5?±34.5; p?<0.001)和术中输血的必要性(18(14.3%)与5(4.0%); p?<0.001)是显着提高,具有主要并发症的患者数量(克拉夫 - Dindo≥≤3)未增加(27(19.8%)与20(15.9%); p?= 0.332)在DP + MVR组中。中期存活分析表明任一组的腺癌和神经内分泌肿瘤没有显着差异。结论DP + MVR是一种可行和安全的外科手术,以实现自由基肿瘤去除,可提供有益的生存结果。虽然DP + MVR后,术后时间和术中输血增强,POPF,PPH或主要并发症(CLAVIEN-DINDO≥β3)不会显着增加。因此,可以在选择的患者中建议DP + MVR以在跨学科策略的概念中切除延长的肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号